OGN vs PROF · P/E 3.4, rev $6.40B vs rev $10.7M
Organon & Co (OGN) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. PROF currently screens at market cap $238.7M.
Not investment advice. Open the OGN and PROF stock pages for the full models.
Not investment advice.